UK Analgesics Market Report: Trends, Growth and Forecast (2026-2032)

By Product (Systemic Analgesics (Adult Analgesics, Paediatric Analgesics, Combined Systemic Analgesics), Topical Analgesics/Anaesthetic), By Drug Type (Opioid Analgesics (Strong Opioids, Weak Opioids), Non-opioid Analgesics (Acetaminophen, Aspirin, Combination Products, Diclofenac, Dipyrone, Ibuprofen, Ketoprofen, Naproxen, OTC Triptans), Compound/Combination Analgesics (Opioid + Non-Opioid Combinations, Multi-Ingredient Non-Opioid Combinations)), By Route of Administration (Oral, Parenteral/Injectable, Topical/External, Transdermal, Rectal/Other), By Pain Type (Acute Pain, Chronic Pain, Breakthrough Pain), By Application (Surgical & Post-operative Pain, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Migraine/Headache, Dental Pain, Others), By Sales Channel (Retail Offline (Offline Pharmacies, Hospital Pharmacies), Retail Online (Online Pharmacies)), By Prescription Type (Prescription, OTC), By Formulation (Tablets, Capsules, Liquids, Injectables, Gels/Creams, Patches), By End User (Hospitals, Clinics/ASCs, Homecare), By Region (England, Wales, Scotland, Northern Ireland)

Report Code:
VI1640
Pages:
170
Category:
Healthcare
Formats:
PDF PPT Excel
Global
Countries
Australia
China
Egypt
France
India
Japan
Kenya
Malaysia
Mexico
Netherlands
Norway
Philippines
Saudi Arabia
Thailand
Turkey
UAE
UK Analgesics Market Report: Trends, Growth and Forecast (2026-2032)

Major Players

  • Boots UK Ltd
  • Dendron Brands Ltd
  • Combe International Ltd
  • Reckitt Benckiser Group Plc (RB)
  • Haleon Plc
  • McNeil Healthcare (UK) Ltd

UK Analgesics Market Statistics and Insights, 2026

  1. Market Size Statistics
    1. Analgesics market size in UK was valued at USD 1.34 billion in 2025 and is estimated at USD 1.36 million in 2026.
    2. The market size is expected to grow to USD 1.47 billion by 2032.
    3. Market to register a CAGR of around 1.33% during 2026-32.
  2. Product Shares
    1. Systemic analgesics grabbed market share of 80%.
  3. Competition
    1. More than 10 companies are actively engaged in producing analgesics in UK.
    2. Top 5 companies acquired around 65% of the market share.
    3. Boots UK Ltd, Dendron Brands Ltd, Combe International Ltd, Reckitt Benckiser Group Plc (RB), Haleon Plc etc., are few of the top companies.
  4. Sales Channel
    1. Retail offline grabbed 75% of the market.

UK Analgesics Market Outlook

UK analgesics market size was valued at USD 1.34 billion in 2025 and is projected to grow from USD 1.36 billion in 2026 to USD 1.47 billion by 2032, exhibiting a CAGR of 1.33% during the forecast period. The growth is stable because consumers are still purchasing pain relief products to use on a regular basis due to the necessity of the products and the fact that demand is stable throughout the country.

The demand is also maintained by the increasing self care practices where more consumers treat headaches, body pain, menstrual pain, and other minor ailments at home rather than visiting a clinic immediately. This shift is advantageous to analgesics since consumers desire fast, convenient, and affordable OTC pain relief. This behaviour is also supported by pressure on the healthcare system and keeps well known products like acetaminophen and ibuprofen in constant use.

By product, systemic analgesics hold the highest share at around 80%, supported by strong trust in widely used oral pain relief products for common discomforts. Simultaneously, the price sensitivity is also a significant issue, with a significant number of consumers shifting to the private label in mild and frequent pain. This is pushing branded analgesics to strain more on value, packaging and more explicit positioning to keep consumer interest.

By sales channel, retail offline leads with around 75% share, as pharmacies, chemists, and supermarkets remain the preferred places to buy analgesics. Pharmacies are particularly successful since shoppers appreciate trusted store settings and advice when selecting appropriate OTC products. Nevertheless, online buying is still on the increase, and it is backed by convenience, price comparison, expanded selection, and repeat purchasing behaviors among younger and digitally assured consumers.

Donut chart showing market share of key players in the UK analgesics market

UK Analgesics Market Growth Driver

Self-Care Becomes a First Response

Analgesics in the UK are a significant growth driver through self medication. Consumers are also taking more headaches, body pain, menstrual pain and other minor illnesses at home rather than going to the clinic immediately. This is maintaining a stable demand on the well known OTC products like acetaminophen, ibuprofen, and more specific pain relief products, particularly as consumers seek fast, convenient, and affordable pain relief.

This behaviour is supported by pressure on the healthcare system. According to NHS England, the waiting list has reduced to 7.29 million in February 2026, and staff provided a record 18.4 million treatments and operations in 2025. Despite this development, lengthy queues still influence health choices, which justifies increased dependence on OTC analgesics to manage common symptoms throughout the UK.

UK Analgesics Market Challenge

Value Pressure Favors Cheaper Alternatives

One of the major obstacles facing analgesics in the UK is price sensitivity. A large number of consumers are shifting to using their own label pain reliever when dealing with mild and frequent pain since they do not necessarily perceive sufficient value in spending more on branded products. This is putting pressure on manufacturers to defend brand value by packaging, marketing and better positioning of products.

This conservative spending climate is reflected in official inflation data. The Office for National Statistics reports that CPI rises by 3.2% in the 12 months to November 2025. Within this context, everyday healthcare purchases are more closely compared in terms of price, and branded analgesics struggle more to sustain differentiation when cheaper retailer owned products are still common and trusted by customers.

Unlock Market Intelligence

Explore the market potential with our data-driven report

Get Sample Pages →

UK Analgesics Market Trend

Digital Buying Changes Purchase Habits

The UK analgesics category is becoming a definite trend in digital purchasing. Customers are becoming more convenient in their e-commerce, comparing prices, having a broader product selection, and making repeat purchases more easily. This is particularly evident among younger and digitally confident consumers who seek improved deals, loyalty programs, and auto refill features of frequently used pain relief products.

This shift is supported by official data. The Office for National Statistics states that online sales account for 28.2% of total retail sales in Great Britain in January 2026. NHS England also states that the NHS App has over 39 million registered users, and 67.8 million repeat prescriptions have been ordered using the app in the 12 months to 30 November 2025. This broader digital behaviour facilitates greater online interaction in daily healthcare buying.

UK Analgesics Market Opportunity

Older Households Expand Daily Pain-Relief Need

The UK has a good opportunity with analgesics due to an ageing population. The elderly have more common joint, muscle, and chronic pain issues, which justifies consistent demand of available OTC pain relief. This also opens up space to products that are more easily comprehended, more easily operated and more specifically focused on particular pain like back pain, discomfort caused by arthritis and other daily ailments.

According to the ONS data, 4.3 million individuals aged 65 years and above are living alone in the UK in 2024, compared to 3.5 million in 2014. It also reports that 51.1% of all people living alone in 2024 are aged 65 years or over. This increases the demand of useful self care items, such as analgesics, that facilitate self management of daily pain at home.

Unlock Market Intelligence

Explore the market potential with our data-driven report

Get Sample Pages →

UK Analgesics Market Segmentation Analysis

By Product

  • Systemic Analgesics
    • Adult Analgesics
    • Paediatric Analgesics
    • Combined Systemic Analgesics
  • Topical Analgesics/Anaesthetic

The segment with the highest share under the product is systemic analgesics, holding around 80% of the UK analgesics market in value terms. This segment is leading since consumers in the UK still use popular oral pain relief products to treat headaches, fever, muscle pain, and other common pains. Good knowledge of the existing drugs like acetaminophen and ibuprofen also facilitates repeat buying and maintains the demand constant throughout the market.

Systemic analgesics are still doing well because trusted brands are still widely available and used regularly in homes. Their stance is also justified by the increasing self care trends where most consumers are opting to treat minor pain at home rather than visiting a doctor to treat common ailments. The necessity of pain relief products, along with high brand trust, makes this segment dominant throughout the forecast period, despite the continued growth of topical and specialised products in the market.

Pie chart showing UK analgesics market segmentation by product and sales channel

By Sales Channel

  • Retail Offline
    • Offline Pharmacies
    • Hospital Pharmacies
  • Retail Online
    • Online Pharmacies

The segment with the highest share under the sales channel is retail offline, accounting for around 75% of the UK analgesics market in value terms. This channel is the best since consumers still like purchasing analgesics in pharmacies, chemists, and supermarkets where they can easily compare brands, formats, and strength levels before making a purchase. The high store presence of pain relief products in the country continues to push offline sales far ahead of other sales channels.

In the retail offline, the pharmacies are the most robust section of the segment, with consumer confidence and the added advantage of in store advice when choosing appropriate OTC pain relief products. Large chains like Boots and Superdrug still appeal to customers who desire quality products and confidence in their use. This segment is also supported by supermarkets based on convenience and competitive pricing, which are helping retail offline to remain at the top despite the increasing retail online.

List of Companies Covered in UK Analgesics Market

The companies listed below are highly influential in the UK analgesics market, with a significant market share and a strong impact on industry developments.

  • Boots UK Ltd
  • Dendron Brands Ltd
  • Combe International Ltd
  • Reckitt Benckiser Group Plc (RB)
  • Haleon Plc
  • McNeil Healthcare (UK) Ltd
  • Omega Pharma Ltd
  • Mentholatum Co Ltd The
  • Kobayashi Healthcare Europe Ltd
  • Bayer Plc

Competitive Landscape

In 2025, the analgesics market in the UK was led by Reckitt Benckiser Group Plc, which maintained its top position driven by the strong performance of its Nurofen brand, supported by targeted campaigns and continued consumer trust, while Haleon Plc ranked second, benefiting from the sustained popularity of its Panadol and Voltarol brands, with both companies operating in a mature yet resilient market shaped by rising self-medication, growing demand for topical and targeted pain relief solutions, and increasing competition from private label products amid ongoing price sensitivity.

Frequently Asked Questions

   A. UK analgesics market is anticipated to register a CAGR of approximately 1.33% during the forecast period.

   A. Market size of UK analgesics market in 2025 was valued at around USD 1.34 Billion.

   A. Self-care becomes a first response is a key factor driving the growth of the analgesics in UK.

   A. Systemic analgesics held the largest market share by value in UK analgesics market in 2025.

   A. Older households expand daily pain-relief need represents a significant growth opportunity for the UK analgesics market.

   A. Value pressure favors cheaper alternatives continues to pose a major challenge for the UK analgesics market.

   A. Digital buying changes purchase habits stands out as a prominent trend boosting the growth of the UK analgesics market.
  1. Market Segmentation
    1. Research Scope
    2. Research Methodology
    3. Definitions and Assumptions
  2. Executive Summary
  3. UK Analgesics Market Policies, Regulations, and Standards
  4. UK Analgesics Market Dynamics
    1. Growth Factors
    2. Challenges
    3. Trends
    4. Opportunities
  5. UK Analgesics Market Statistics, 2022-2032F
    1. Market Size & Growth Outlook
      1. By Revenues in USD Million
    2. Market Segmentation & Growth Outlook
      1. By Product
        1. Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
          1. Adult Analgesics- Market Insights and Forecast 2022-2032, USD Million
          2. Paediatric Analgesics- Market Insights and Forecast 2022-2032, USD Million
          3. Combined Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
        2. Topical Analgesics/Anaesthetic- Market Insights and Forecast 2022-2032, USD Million
      2. By Drug Type
        1. Opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
          1. Strong Opioids- Market Insights and Forecast 2022-2032, USD Million
          2. Weak Opioids- Market Insights and Forecast 2022-2032, USD Million
        2. Non-opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
          1. Acetaminophen- Market Insights and Forecast 2022-2032, USD Million
          2. Aspirin- Market Insights and Forecast 2022-2032, USD Million
          3. Combination Products- Market Insights and Forecast 2022-2032, USD Million
          4. Diclofenac- Market Insights and Forecast 2022-2032, USD Million
          5. Dipyrone- Market Insights and Forecast 2022-2032, USD Million
          6. Ibuprofen- Market Insights and Forecast 2022-2032, USD Million
          7. Ketoprofen- Market Insights and Forecast 2022-2032, USD Million
          8. Naproxen- Market Insights and Forecast 2022-2032, USD Million
          9. OTC Triptans- Market Insights and Forecast 2022-2032, USD Million
        3. Compound/Combination Analgesics- Market Insights and Forecast 2022-2032, USD Million
          1. Opioid + Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
          2. Multi-Ingredient Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
      3. By Route of Administration
        1. Oral- Market Insights and Forecast 2022-2032, USD Million
        2. Parenteral/Injectable- Market Insights and Forecast 2022-2032, USD Million
        3. Topical/External- Market Insights and Forecast 2022-2032, USD Million
        4. Transdermal- Market Insights and Forecast 2022-2032, USD Million
        5. Rectal/Other- Market Insights and Forecast 2022-2032, USD Million
      4. By Pain Type
        1. Acute Pain- Market Insights and Forecast 2022-2032, USD Million
        2. Chronic Pain- Market Insights and Forecast 2022-2032, USD Million
        3. Breakthrough Pain- Market Insights and Forecast 2022-2032, USD Million
      5. By Application
        1. Surgical & Post-operative Pain- Market Insights and Forecast 2022-2032, USD Million
        2. Musculoskeletal Pain- Market Insights and Forecast 2022-2032, USD Million
        3. Neuropathic Pain- Market Insights and Forecast 2022-2032, USD Million
        4. Cancer Pain- Market Insights and Forecast 2022-2032, USD Million
        5. Migraine/Headache- Market Insights and Forecast 2022-2032, USD Million
        6. Dental Pain- Market Insights and Forecast 2022-2032, USD Million
        7. Others- Market Insights and Forecast 2022-2032, USD Million
      6. By Sales Channel
        1. Retail Offline- Market Insights and Forecast 2022-2032, USD Million
          1. Offline Pharmacies- Market Insights and Forecast 2022-2032, USD Million
          2. Hospital Pharmacies- Market Insights and Forecast 2022-2032, USD Million
        2. Retail Online- Market Insights and Forecast 2022-2032, USD Million
          1. Online Pharmacies- Market Insights and Forecast 2022-2032, USD Million
      7. By Prescription Type
        1. Prescription- Market Insights and Forecast 2022-2032, USD Million
        2. OTC- Market Insights and Forecast 2022-2032, USD Million
      8. By Formulation
        1. Tablets- Market Insights and Forecast 2022-2032, USD Million
        2. Capsules- Market Insights and Forecast 2022-2032, USD Million
        3. Liquids- Market Insights and Forecast 2022-2032, USD Million
        4. Injectables- Market Insights and Forecast 2022-2032, USD Million
        5. Gels/Creams- Market Insights and Forecast 2022-2032, USD Million
        6. Patches- Market Insights and Forecast 2022-2032, USD Million
      9. By End User
        1. Hospitals- Market Insights and Forecast 2022-2032, USD Million
        2. Clinics/ASCs- Market Insights and Forecast 2022-2032, USD Million
        3. Homecare- Market Insights and Forecast 2022-2032, USD Million
      10. By Region
        1. England
        2. Wales
        3. Scotland
        4. Northern Ireland
      11. By Competitors
        1. Competition Characteristics
        2. Market Share & Analysis
  6. UK Systemic Analgesics Market Statistics, 2022-2032
    1. Market Size & Growth Outlook
      1. By Revenues in USD Million
    2. Market Segmentation & Growth Outlook
      1. By Drug Type- Market Insights and Forecast 2022-2032, USD Million
      2. By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
      3. By Pain Type- Market Insights and Forecast 2022-2032, USD Million
      4. By Application- Market Insights and Forecast 2022-2032, USD Million
      5. By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
      6. By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
      7. By Formulation- Market Insights and Forecast 2022-2032, USD Million
      8. By End User- Market Insights and Forecast 2022-2032, USD Million
      9. By Region- Market Insights and Forecast 2022-2032, USD Million
  7. UK Topical Analgesics/Anaesthetic Market Statistics, 2022-2032
    1. Market Size & Growth Outlook
      1. By Revenues in USD Million
    2. Market Segmentation & Growth Outlook
      1. By Drug Type- Market Insights and Forecast 2022-2032, USD Million
      2. By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
      3. By Pain Type- Market Insights and Forecast 2022-2032, USD Million
      4. By Application- Market Insights and Forecast 2022-2032, USD Million
      5. By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
      6. By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
      7. By Formulation- Market Insights and Forecast 2022-2032, USD Million
      8. By End User- Market Insights and Forecast 2022-2032, USD Million
      9. By Region- Market Insights and Forecast 2022-2032, USD Million
  8. Competitive Outlook
    1. Company Profiles
      1. Reckitt Benckiser Group Plc (RB)
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Haleon Plc
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      3. McNeil Healthcare (UK) Ltd
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Omega Pharma Ltd
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Mentholatum Co Ltd The
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Boots UK Ltd
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Dendron Brands Ltd
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Combe International Ltd
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Kobayashi Healthcare Europe Ltd
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Bayer Plc
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
  9. Disclaimer
SegmentSub-Segment
By Product
  • Systemic Analgesics
    • Adult Analgesics
    • Paediatric Analgesics
    • Combined Systemic Analgesics
  • Topical Analgesics/Anaesthetic
By Drug Type
  • Opioid Analgesics
    • Strong Opioids
    • Weak Opioids
  • Non-opioid Analgesics
    • Acetaminophen
    • Aspirin
    • Combination Products
    • Diclofenac
    • Dipyrone
    • Ibuprofen
    • Ketoprofen
    • Naproxen
    • OTC Triptans
  • Compound/Combination Analgesics
    • Opioid + Non-Opioid Combinations
    • Multi-Ingredient Non-Opioid Combinations
By Route of Administration
  • Oral
  • Parenteral/Injectable
  • Topical/External
  • Transdermal
  • Rectal/Other
By Pain Type
  • Acute Pain
  • Chronic Pain
  • Breakthrough Pain
By Application
  • Surgical & Post-operative Pain
  • Musculoskeletal Pain
  • Neuropathic Pain
  • Cancer Pain
  • Migraine/Headache
  • Dental Pain
  • Others
By Sales Channel
  • Retail Offline
    • Offline Pharmacies
    • Hospital Pharmacies
  • Retail Online
    • Online Pharmacies
By Prescription Type
  • Prescription
  • OTC
By Formulation
  • Tablets
  • Capsules
  • Liquids
  • Injectables
  • Gels/Creams
  • Patches
By End User
  • Hospitals
  • Clinics/ASCs
  • Homecare
By Region
  • England
  • Wales
  • Scotland
  • Northern Ireland

Research Methodology

This study followed a structured approach comprising four key phases to assess the size and scope of the electro-oxidation market. The process began with thorough secondary research to collect data on the target market, related markets, and broader industry context. These findings, along with preliminary assumptions and estimates, were then validated through extensive primary research involving industry experts from across the value chain. To calculate the overall market size, both top-down and bottom-up methodologies were employed. Finally, market segmentation and data triangulation techniques were applied to refine and validate segment-level estimations.

Secondary Research

The secondary research phase involved gathering data from a wide range of credible and published sources. This step helped in identifying industry trends, defining market segmentation, and understanding the market landscape and value chain.

Sources consulted during this phase included:

  • Company annual reports, investor presentations, and press releases
  • Industry white papers and certified publications
  • Trade directories and market-recognized databases
  • Articles from authoritative authors and reputable journals
  • Gold and silver standard websites

Secondary research was critical in mapping out the industry's value chain and monetary flow, identifying key market segments, understanding regional variations, and tracking significant industry developments.

Other key sources:

  • Financial disclosures
  • Industry associations and trade bodies
  • News outlets and business magazines
  • Academic journals and research studies
  • Paid industry databases

Primary Research

To validate secondary data and gain deeper market insights, primary research was conducted with key stakeholders across both the supply and demand sides of the market.

On the demand side, participants included decision-makers and influencers from end-user industries—such as CIOs, CTOs, and CSOs—who provided first-hand perspectives on market needs, product usage, and future expectations.

On the supply side, interviews were conducted with manufacturers, industry associations, and institutional participants to gather insights into current offerings, product pipelines, and market challenges.

Primary interviews provided critical inputs such as:

  • Market size and revenue data
  • Product and service breakdowns
  • Market forecasts
  • Regional and application-specific trends

Stakeholders consulted included:

  • Leading OEM and solution providers
  • Channel and distribution partners
  • End users across various applications
  • Independent consultants and industry specialists

Market Size Estimation and Data Triangulation

  • Identifying Key Market Participants (Secondary Research)
    • Goal: To identify the major players or companies in the target market. This typically involves using publicly available data sources such as industry reports, market research publications, and financial statements of companies.
    • Tools: Reports from firms like Gartner, Forrester, Euromonitor, Statista, IBISWorld, and others. Public financial statements, news articles, and press releases from top market players.
  • Extracting Earnings of Key Market Participants
    • Goal: To estimate the earnings generated from the product or service being analyzed. This step helps in understanding the revenue potential of each market player in a specific geography.
    • Methods: Earnings data can be gathered from:
      • Publicly available financial reports (for listed companies).
      • Interviews and primary data sources from professionals, such as Directors, VPs, SVPs, etc. This is especially useful for understanding more nuanced, internal data that isn't publicly disclosed.
      • Annual reports and investor presentations of key players.
  • Data Collation and Development of a Relevant Data Model
    • Goal: To collate inputs from both primary and secondary sources into a structured, data-driven model for market estimation. This model will incorporate key market KPIs and any independent variables relevant to the market.
    • Key KPIs: These could include:
      • Market size, growth rate, and demand drivers.
      • Industry-specific metrics like market share, average revenue per customer (ARPC), or average deal size.
      • External variables, such as economic growth rates, inflation rates, or commodity prices, that could affect the market.
    • Data Modeling: Based on this data, the market forecasts are developed for the next 5 years. A combination of trend analysis, scenario modeling, and statistical regression might be used to generate projections.
  • Scenario Analysis
    • Goal: To test different assumptions and validate how sensitive the market is to changes in key variables (e.g., market demand, regulatory changes, technological disruptions).
    • Types of Scenarios:
      • Base Case: Based on current assumptions and historical data.
      • Best-Case Scenario: Assuming favorable market conditions, regulatory environments, and technological advancements.
      • Worst-Case Scenario: Accounting for adverse factors, such as economic downturns, stricter regulations, or unexpected disruptions.